Authored By: Sarah
12 Aug 2024

 Proteomics Market Size to grow by USD 33999.4 million between 2024-2028

According to a research report “ Proteomics Market” by Product (Reagents, Instruments, Services) End-user (Clinical diagnostics, Drug discovery, Others) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 33999.4 million, at a CAGR of 16.83% during the forecast period. The global proteomics market is experiencing significant growth due to the rapid advancements in proteomics research. Proteomics refers to the comprehensive analysis of an organism's proteins, which is crucial for understanding biological processes and disease mechanisms. Technological innovations, such as mass spectrometry, chromatography, and bioinformatics, have revolutionized proteomics research, leading to the development of high-throughput techniques like mass spectrometry-based proteomics and protein microarrays. These advances enable the analysis of vast protein datasets with increased sensitivity and throughput, thereby providing new insights into protein functions and their roles in health and disease..

Browse market data tables, figures, and in-depth TOC on “Proteomics Market” by Product (Reagents, Instruments, Services) End-user (Clinical diagnostics, Drug discovery, Others) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample

By Product, the Reagents segment is projected to dominate the market size in 2024

The Proteomics Market represents a significant business opportunity for companies specializing in life sciences research and diagnostics. This sector's growth is driven by the increasing demand for protein-level analysis in various industries, including pharmaceuticals, agriculture, and academia. Advanced technologies, such as mass spectrometry and two-dimensional gel electrophoresis, facilitate the identification and quantification of proteins, enhancing research and development efforts. Proteomics market size is projected to expand at a robust CAGR, driven by technological advancements, growing research funding, and rising applications in personalized medicine.

By End-user, Clinical diagnostics  segment is expected to hold the largest market size for the year 2024

The proteomics market represents a significant growth opportunity for businesses, driven by the increasing demand for large-scale protein identification and quantification. This sector is witnessing substantial investment due to its potential applications in various industries, including healthcare, agriculture, and biotechnology. Advanced technologies, such as mass spectrometry and two-dimensional gel electrophoresis, are fueling innovation and enabling new solutions for protein analysis. Market size is projected to expand at a robust CAGR through 2027.

North America is forecasted to hold the largest market size by region in 2024

The proteomics market represents a significant growth opportunity for businesses, driven by the increasing demand for large-scale protein identification and quantification. This sector is witnessing rapid advancements in technology, enabling more comprehensive and accurate analysis of proteins. Companies investing in proteomics can expect to reap rewards through the development of innovative diagnostic tools, therapeutic discoveries, and improved research capabilities. The market's potential is vast, with applications spanning various industries, including healthcare, agriculture, and biotechnology.

The Proteomics Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Agilent Technologies Inc.
  • Applied Biomics Inc.
  • Bio Rad Laboratories Inc.
  • Biognosys AG
  • Bruker Corp.
  • Cell Signaling Technology Inc.
  • CellCarta Biosciences Inc.
  • Creative Proteomics
  • DiaSorin Spa
  • F. Hoffmann La Roche Ltd.
  • Geno Technology Inc.
  • HORIBA Ltd.
  • Illumina Inc.
  • Merck KGaA
  • Olink Holding AB
  • Perkin Elmer Inc.
  • Promega Corp.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • Waters Corp.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

Proteomics, the large-scale study of proteins and their functions, plays a crucial role in advancing our understanding of disease mechanisms and facilitating personalized medicine. By identifying protein functions, interactions, modifications, and abundances, proteomics enables the discovery of biomarkers for various diseases, including birth and genetic disorders. Informatics tools and data analysis techniques are essential for handling the vast amounts of data generated through high-throughput proteomic technologies, such as mass spectrometry and next-generation sequencing. Data integration and resolution are key aspects of proteomics, allowing for the analysis of complex cellular processes and networks involving interacting partners and modifications. Proteomics technology also includes the use of antibodies, DNA aptamers, and other reagents for targeting specific proteins, contributing to drug development and therapeutic target discovery. Ensuring the scalability and reproducibility of proteomic techniques is essential for advancing our knowledge in this field and translating it into clinical applications.

Market Research Overview

Proteomics is a rapidly growing field of science that focuses on the large-scale analysis of proteins, their functions, interactions, and modifications. The Proteomics Market encompasses various segments, including Immunoassay reagents, Protein fractionation, Protein microarrays, Electrophoresis, Chromatography, Spectroscopy, Data management, and Proteomic technologies. Immunoassay reagents, Protein microarrays, and Electrophoresis are key techniques for protein profiling and interaction analysis. Chromatography and Spectroscopy are used for protein separation and identification. Data management, informatics tools, and data analysis are essential for handling the vast amounts of data generated by these techniques. Proteomics technologies include Mass spectrometry, X-ray Crystallography, and Nanotechnology. Mass spectrometry is a powerful tool for protein identification and quantification. Protein-protein interactions, modifications, variations, and protein abundances can be studied using these technologies. Proteomics research is crucial for understanding disease mechanisms, protein functions, personalized medicine, and drug discovery. Biomarker discovery, therapeutic targets, and drug development are major applications of proteomics. The Proteomics Market is driven by healthcare expenditure, awareness, and funding. Industry players offer services, instruments, tools, and maintenance. Sample types and species vary widely, from human to animal and plant. Polyclonal antibodies, ELISA sandwich approach, and kinetics are important techniques used in protein biology research. The market faces challenges such as reproducibility, scalability, and cost. Robotics and high-throughput analysis are used to address these challenges. Proteomics instruments and tools are becoming more sophisticated, with improvements in resolution, sensitivity, and multiplexed analysis. In conclusion, the Proteomics Market is a dynamic and evolving field that offers significant opportunities for research and development in various industries, including healthcare, pharmaceuticals, and academia.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio